Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04450537 · ClinicalTrials.gov registry record · NA
PACE Vape Messaging Study
A NA study of Vaping and Electronic Cigarette Use, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 569
- Enrollment target
- 1
- Study location
NCT04450537 is a NA study of Vaping and Electronic Cigarette Use that has completed, run by University of Vermont. The registered enrollment target is 569 participants, below the 729-participant average among 18 other Vaping trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04450537, a NA study of Vaping and Electronic Cigarette Use, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 569 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the effect of exposure to vape education messages on beliefs, perceptions, norms, and behaviors related to electronic vapor product use.
Conditions Studied
Interventions
- BEHAVIORAL Vape Messaging Intervention
Study Locations (1)
Vermont
- University of Vermont - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 569 participants |
| Start Date | 2020-06-23 |
| Est. Completion | 2020-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04450537
The ClinicalTrials.gov registry entry for NCT04450537 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 569 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 729-participant average among 18 other Vaping trials with a reported enrollment target (22% lower). The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Vaping appearing as the primary indexed condition, and to 1 intervention - of which Vape Messaging Intervention is the first listed.
NCT04450537 reports 1 study location spanning 1 distinct geographic area - top geographies include Vermont.
Frequently Asked Questions
What is clinical trial NCT04450537 about?
NCT04450537 is a clinical study titled "PACE Vape Messaging Study". The purpose of this study is to examine the effect of exposure to vape education messages on beliefs, perceptions, norms, and behaviors related to electronic vapor product use.
What is the current status of trial NCT04450537?
This trial is currently completed. It is a NA study. The enrollment target is 569 participants. The study started on 2020-06-23. Estimated completion is 2020-09-30.
What conditions does trial NCT04450537 study?
This clinical trial studies the following conditions: Vaping, Electronic Cigarette Use, E-cigarette Use.
What interventions are being tested in trial NCT04450537?
The interventions under investigation include: Vape Messaging Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04450537?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04450537 being conducted?
This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaping
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study
RECRUITING · NA
-
Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults
RECRUITING · NA
-
Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol
RECRUITING · NA
-
Behavioral Intervention for Youth to Promote Vaping Cessation
RECRUITING · NA
-
Implementing an Adolescent and Young Adult (AYA) mHealth Vaping Cessation Program Into Oncology Clinics
RECRUITING · NA
-
Network Intervention to Prevent Vaping
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.